Insights on the Contraceptives Global Market to 2028

company logo

Global contraceptive market

Global contraceptive market

Global contraceptive market

DUBLIN, April 8, 2022 (GLOBE NEWSWIRE) — The “Contraceptive Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2021-2028” Report has been added ResearchAndMarkets.com Offer.

This report on the global contraceptive pills market examines past as well as current growth trends and opportunities to gain valuable insights into the market indicators during the forecast period 2021-2028. The report provides the revenue of the global contraceptives market for the period 2017-2028, considering 2018 as the base year and 2028 as the forecast year. The report also includes the compound annual growth rate (CAGR) for the global contraceptive pills market during the forecast period.

The report was created after extensive primary and secondary research. Primary research comprised much of the research effort, which involved analysts conducting interviews with industry leaders and opinion leaders. Extensive secondary research included referencing product literature, annual reports, press releases, and relevant documents from key players to understand the global contraceptive market.

Secondary research also included internet sources, statistical data from government agencies, websites, company presentations, sales data and trade associations. Analysts have used a combination of top-down and bottom-up approaches to study various phenomena in the global contraceptive market.

The report provides an in-depth summary as well as a snapshot of the growth behavior of various segments included in the scope of the study. Additionally, the report sheds light on changing competitive dynamics in the global contraceptive pills market. These indices serve as valuable tools for existing market participants as well as companies interested in entering the global contraceptive market.

The report addresses the competitive landscape of the global contraceptive pills market. Key players operating in the global contraceptive pills market have been identified and each of them have been profiled on different business attributes. Company overview, financial standing, recent developments and SWOT are some of the attributes of players in the global contraceptive pills market that have been profiled in this report.

Important Key questions answered in Birth Control Pills market report

  • What is the growth rate of product companies in the global contraceptive pills market?

  • What will be the YoY growth of the Global Contraceptive Drugs Market from 2017 to 2028?

  • What is the impact of changing technology trends on the global contraceptive market?

  • Will North America be the most profitable market for contraceptive suppliers?

  • What factors are expected to hamper the growth of the global contraceptive pills market during the forecast period?

  • Who are the leading companies in the global Contraceptive Drugs Market?

Main topics covered:

1 Introduction

2. Assumptions and research methodology

3. Summary: Global Birth Control Pills Market

4. Market Overview
4.1. introduction
4.2. overview
4.3. Important market indicators
4.4. market dynamics
4.4.1. driver
4.4.2. limitations
4.4.3. opportunity
4.5. Global Contraceptive Drugs Market Analysis and Forecast, 2017-2028
4.5.1. Market Revenue Projections (Million USD)
4.6. Global Contraceptive Drugs Market – Global Supply Demand Scenario
4.7. Porter’s Five Forces Analysis
4.8. Analysis of the value chain
4.9. market prospects

5. Global Contraceptive Drugs Market Analysis and Forecast by Product
5.1. Introduction & Definition
5.2. Important findings / developments
5.3. key trends
5.4. Market Value Forecast, by Product, 2017-2028
5.4.1. contraceptives
5.4.1.1. Oral contraceptives
5.4.1.1.1. Combined contraceptives
5.4.1.1.2. mini pills
5.4.1.2. contraceptive injectable
5.4.1.3. Topical contraceptive patch
5.4.2. contraceptives
5.4.2.1. Male contraceptives
5.4.2.2. contraceptives for women
5.4.2.2.1. female condoms
5.4.2.2.2. contraceptive diaphragms
5.4.2.2.3. contraceptive sponges
5.4.2.2.4. contraceptive vaginal rings
5.4.2.2.5. intrauterine devices
5.4.2.2.6. Subdermal contraceptive implants
5.4.2.2.7. Non-surgical permanent contraceptive devices
5.5. Market Attractiveness Analysis by Product

6. Global Birth Control Pills Market Analysis and Forecast by Distribution Channel
6.1. Introduction & Definition
6.2. Important findings / developments
6.3. key trends
6.4. Market value forecast, by distribution channel, 2017-2028
6.4.1. hospital pharmacy
6.4.1.1. Public
6.4.1.2. Private
6.4.2. Independent Pharmacy
6.4.3. online platform
6.4.4. clinics
6.4.5. Other
6.5. Market attractiveness analysis by distribution channel

7. Global Contraception Market Analysis and Forecast by Region
7.1. Important Findings
7.2. Policies and Regulations
7.3. Market value forecast by region
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Latin America
7.3.5. Middle East and Africa
7.4. Market attractiveness analysis by country/region

8. North America Contraceptive Drugs Market Analysis and Forecast

9. European Contraceptive Drugs Market Analysis and Forecast

10. Asia-Pacific Contraceptive Drugs Market Analysis and Forecast

11. Contraceptive Drugs Market Analysis and Forecast in Latin America

12. Middle East and Africa Contraceptive Drugs Market Analysis and Forecast

13. Competitive Landscape
13.1. Market Participants – Competitive Matrix (by Tier and Size of Firms)
13.2. Market share analysis, by company, 2020
13.3. company profiles
13.3.1. Merck & Co., Inc.
13.3.1.1. overview
13.3.1.2. finance
13.3.1.3. Recent Developments
13.3.1.4. strategy
13.3.2. Cipla, Inc.
13.3.2.1. overview
13.3.2.2. finance
13.3.2.3. Recent Developments
13.3.2.4. strategy
13.3.3. Allergan plc
13.3.3.1. overview
13.3.3.2. finance
13.3.3.3. Recent Developments
13.3.3.4. strategy
13.3.4. Bayer AG
13.3.4.1. overview
13.3.4.2. finance
13.3.4.3. Recent Developments
13.3.4.4. strategy
13.3.5. HLL Lifecare Limited
13.3.5.1. overview
13.3.5.2. finance
13.3.5.3. Recent Developments
13.3.5.4. strategy
13.3.6. humanity pharma
13.3.6.1. overview
13.3.6.2. finance
13.3.6.3. Recent Developments
13.3.6.4. strategy
13.3.7. Pfizer, Inc.
13.3.7.1. overview
13.3.7.2. finance
13.3.7.3. Recent Developments
13.3.7.4. strategy
13.3.8. Teva Pharmaceutical Industries Ltd.
13.3.8.1. overview
13.3.8.2. finance
13.3.8.3. Recent Developments
13.3.8.4. strategy
13.3.9. Mithra Pharmaceuticals
13.3.9.1. overview
13.3.9.2. finance
13.3.9.3. Recent Developments
13.3.9.4. strategy
13.3.10. Pharmaceutical company Janssen
13.3.10.1. overview
13.3.10.2. finance
13.3.10.3. Recent Developments
13.3.10.4. strategy
13.3.11. Reckitt Benckiser Group plc
13.3.11.1. overview
13.3.11.2. finance
13.3.11.3. Recent Developments
13.3.11.4. strategy

For more information about this report, see https://www.researchandmarkets.com/r/q9db0e

attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Leave a Comment